Rhesus monkey TRIM5α SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the

Nikolaos Biris1, Andrei Tomashevski, Akash Bhattacharya

  • 1Department of Biochemistry and Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

Insights

The restriction factor TRIM5α binds to retroviral capsids, blocking replication. Its SPRY domain uses mobile loops for extensive capsid interaction, with multimerization driving restriction efficacy.

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • The restriction factor TRIM5α inhibits retroviral replication by binding to the viral capsid.
  • Understanding the TRIM5α-capsid interaction is crucial for HIV tropism and host-pathogen dynamics.
  • The precise molecular interface of this interaction remains poorly defined.

Purpose of the Study:

  • To investigate the binding interface between the rhesus TRIM5α SPRY domain and HIV capsid constructs.
  • To elucidate the structural basis of TRIM5α's restriction of retroviral replication.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy was employed to study the binding interactions.
  • Analysis focused on the interaction between the rhesus TRIM5α SPRY domain and HIV capsid fragments.

Main Results:

  • NMR data suggest one TRIM5α SPRY domain interacts with multiple capsid monomers within the assembled core.
  • A mobile SPRY v1 loop appears to mediate inter-hexamer contacts critical for restriction.
  • The interaction interface is extensive, involving mobile loops and multiple epitopes, lacking specific hot spots.

Conclusions:

  • TRIM5α's extensive, low-affinity interactions with capsid monomers, driven by avidity from oligomerization, contribute to retroviral restriction.
  • This binding mechanism may confer resistance to capsid mutations, enhancing TRIM5α's effectiveness.
  • The findings provide molecular insights into TRIM5α-mediated host defense against primate lentiviruses.